Novartis to Buy Breast-Cancer Drug From Synnovation for Up to $3 Billion
wsj.com
Want to monitor TNYA?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor TNYAtenaya therapeutics is a privately-held biopharmaceutical company backed by the column group.